Google bio firm in $1.5 bn alliance against aging ills

September 3, 2014

Google backed life sciences firm Calico and bio-pharmaceutical titan AbbVie on Wednesday announced an alliance to invest $1.5 billion to find ways to battle age-related diseases.

Under the agreement, the companies will combine strengths to discover, develop and bring to market new therapies for illnesses that afflict people as they get old.

The list of targets includes and cancer.

"Our relationship with AbbVie is a pivotal event for Calico, whose mission is to develop life-enhancing therapies for people with age-related diseases," said Calico chief Art Levinson, a former head of Genentech.

" It will greatly accelerate our efforts to understand the science of aging, advance our clinical work, and help bring important new therapies to patients everywhere."

The agreement between the companies will lead to the creation of a premier research and development facility in the San Francisco area.

"This collaboration demonstrates our commitment to exploring new areas of medicine and innovative approaches to drug discovery and development that augments our already robust pipeline," said AbbVie chief executive Richard Gonzalez.

"The potential to help improve patients' lives with new therapies is enormous."

AbbVie and Calico will each provide $250 million at the outset, then later fund the venture with an addition $500 million each, according to terms of the agreement.

AbbVie was spun off from Abbott Laboratories last year to focus on developing ways to treat some of the world's complex and serious diseases.

Calico, short for California Life Sciences, was created by Google with a mission of using advanced technologies to help people live longer, healthier lives.

Explore further: Google promises new thinking for health company

Related Stories

Takeover target Shire promises strong growth

June 23, 2014

Takeover target Shire on Monday highlighted its potential as a standalone drugmaker, offering investors a rosy projection of its earnings potential that it believes is not reflected in the acquisition proposal made by U.S.-based ...

Google's health startup forges venture with AbbVie

September 3, 2014

Google's ambitious health startup is teaming up with biotechnology drugmaker AbbVie in a $500 million joint venture that will try to develop new ways to treat cancer and other diseases such as Alzheimer's.

Recommended for you

Inferring urban travel patterns from cellphone data

August 29, 2016

In making decisions about infrastructure development and resource allocation, city planners rely on models of how people move through their cities, on foot, in cars, and on public transportation. Those models are largely ...

How machine learning can help with voice disorders

August 29, 2016

There's no human instinct more basic than speech, and yet, for many people, talking can be taxing. 1 in 14 working-age Americans suffer from voice disorders that are often associated with abnormal vocal behaviors - some of ...

Apple issues update after cyber weapon captured

August 26, 2016

Apple iPhone owners on Friday were urged to install a quickly released security update after a sophisticated attack on an Emirati dissident exposed vulnerabilities targeted by cyber arms dealers.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

nanotech_republika_pl
not rated yet Sep 03, 2014
"Calico, short for California Life Sciences, was created by Google with a mission of using advanced technologies to help people live longer, healthier lives." They would do better job if they had spent some of that money for the SENS Research Foundation. Just fix the aging cells and tissue.

http://www.sens.o...research

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.